Cargando…
Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques
BG505 SOSIP is a well-characterized near-native recombinant HIV Envelope (Env) trimer that holds promise as part of a sequential HIV immunogen regimen to induce broadly neutralizing antibodies (bnAbs). Rhesus macaques are considered the most appropriate pre-clinical animal model for monitoring antib...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487785/ https://www.ncbi.nlm.nih.gov/pubmed/32905766 http://dx.doi.org/10.1016/j.celrep.2020.108122 |
_version_ | 1783581559965614080 |
---|---|
author | Zhao, Fangzhu Joyce, Collin Burns, Alison Nogal, Bartek Cottrell, Christopher A. Ramos, Alejandra Biddle, Trevor Pauthner, Matthias Nedellec, Rebecca Qureshi, Huma Mason, Rosemarie Landais, Elise Briney, Bryan Ward, Andrew B. Burton, Dennis R. Sok, Devin |
author_facet | Zhao, Fangzhu Joyce, Collin Burns, Alison Nogal, Bartek Cottrell, Christopher A. Ramos, Alejandra Biddle, Trevor Pauthner, Matthias Nedellec, Rebecca Qureshi, Huma Mason, Rosemarie Landais, Elise Briney, Bryan Ward, Andrew B. Burton, Dennis R. Sok, Devin |
author_sort | Zhao, Fangzhu |
collection | PubMed |
description | BG505 SOSIP is a well-characterized near-native recombinant HIV Envelope (Env) trimer that holds promise as part of a sequential HIV immunogen regimen to induce broadly neutralizing antibodies (bnAbs). Rhesus macaques are considered the most appropriate pre-clinical animal model for monitoring antibody (Ab) responses. Accordingly, we report here the isolation of 45 BG505 autologous neutralizing antibodies (nAbs) with multiple specificities from SOSIP-immunized and BG505 SHIV-infected rhesus macaques. We associate the most potent neutralization with two epitopes: the C3/V5 and V1/V3 regions. We show that all of the nAbs bind in close proximity to known bnAb epitopes and might therefore sterically hinder elicitation of bnAbs. We also identify a “public clonotype” that targets the immunodominant C3/V5 nAb epitope, which suggests that common antibody rearrangements might help determine humoral responses to Env immunogens. The results highlight important considerations for vaccine design in anticipation of results of the BG505 SOSIP trimer in clinical trials. |
format | Online Article Text |
id | pubmed-7487785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cell Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-74877852020-09-18 Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques Zhao, Fangzhu Joyce, Collin Burns, Alison Nogal, Bartek Cottrell, Christopher A. Ramos, Alejandra Biddle, Trevor Pauthner, Matthias Nedellec, Rebecca Qureshi, Huma Mason, Rosemarie Landais, Elise Briney, Bryan Ward, Andrew B. Burton, Dennis R. Sok, Devin Cell Rep Article BG505 SOSIP is a well-characterized near-native recombinant HIV Envelope (Env) trimer that holds promise as part of a sequential HIV immunogen regimen to induce broadly neutralizing antibodies (bnAbs). Rhesus macaques are considered the most appropriate pre-clinical animal model for monitoring antibody (Ab) responses. Accordingly, we report here the isolation of 45 BG505 autologous neutralizing antibodies (nAbs) with multiple specificities from SOSIP-immunized and BG505 SHIV-infected rhesus macaques. We associate the most potent neutralization with two epitopes: the C3/V5 and V1/V3 regions. We show that all of the nAbs bind in close proximity to known bnAb epitopes and might therefore sterically hinder elicitation of bnAbs. We also identify a “public clonotype” that targets the immunodominant C3/V5 nAb epitope, which suggests that common antibody rearrangements might help determine humoral responses to Env immunogens. The results highlight important considerations for vaccine design in anticipation of results of the BG505 SOSIP trimer in clinical trials. Cell Press 2020-09-08 /pmc/articles/PMC7487785/ /pubmed/32905766 http://dx.doi.org/10.1016/j.celrep.2020.108122 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhao, Fangzhu Joyce, Collin Burns, Alison Nogal, Bartek Cottrell, Christopher A. Ramos, Alejandra Biddle, Trevor Pauthner, Matthias Nedellec, Rebecca Qureshi, Huma Mason, Rosemarie Landais, Elise Briney, Bryan Ward, Andrew B. Burton, Dennis R. Sok, Devin Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques |
title | Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques |
title_full | Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques |
title_fullStr | Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques |
title_full_unstemmed | Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques |
title_short | Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques |
title_sort | mapping neutralizing antibody epitope specificities to an hiv env trimer in immunized and in infected rhesus macaques |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487785/ https://www.ncbi.nlm.nih.gov/pubmed/32905766 http://dx.doi.org/10.1016/j.celrep.2020.108122 |
work_keys_str_mv | AT zhaofangzhu mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT joycecollin mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT burnsalison mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT nogalbartek mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT cottrellchristophera mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT ramosalejandra mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT biddletrevor mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT pauthnermatthias mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT nedellecrebecca mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT qureshihuma mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT masonrosemarie mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT landaiselise mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT brineybryan mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT wardandrewb mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT burtondennisr mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques AT sokdevin mappingneutralizingantibodyepitopespecificitiestoanhivenvtrimerinimmunizedandininfectedrhesusmacaques |